For research use only.
Catalog No.S2456 Synonyms: Sonazine
CAS No. 69-09-0
Chlorpromazine HCl is a dopamine and potassium channel inhibitor with IC50 of 6.1 and 16 μM for inward-rectifying K+ currents and time-independent outward currents.
Selleck's Chlorpromazine HCl has been cited by 11 publications
5 Customer Reviews
Low-micromolar amounts of chlorpromazine inhibit SARS-CoV-induced cytopathology. Vero E6 cells in 96-well plates were infected with SARS-CoV isolate Frankfurt-1 (MOI, 0.005) in the presence of 0 to 16 μM CPZ (B), given at t of +1 h p.i. Cells were incubated for 3 days, and viability was monitored using an MTS assay. In parallel, potential compound cytotoxicity was monitored in mock-infected Vero E6 cells. Graphs show the results (averages and SD) of a representative experiment that was performed in quadruplicate. All experiments were repeated at least twice. For each compound, the EC50, CC50, and SI values are given.
Antimicrob Agents Chemother, 2014, 58:4875-4884.. Chlorpromazine HCl purchased from Selleck.
Prussian blue staining for cells co-cultured with IOPs (25 mg/mL) and different inhibitors, (C1) control, (C2) LY294002 (100 μM, Selleck), (C3) genistein (10 μM, Selleck), (C4) chlorpromazine (10 μM, Selleck) for 24 h, arrows indicate the stained cells;
Acta Biomater, 2018, 71:49-60. Chlorpromazine HCl purchased from Selleck.
Vero and H1299 cells were pretreated with increasing concentrations of CPZ (CME inhibitor), Amiloride (macropinocytosis inhibitor), or Nystatin (CavME inhibitor) for 30 min and infected with IBV at MOI= 1. H2O or DMSO pretreatment in parallel experiments was set as control. The incoming virus level was determined by quantification of viral gRNA at 2 h.p.i.; the expression level of IBV N protein was analyzed at 8 h.p.i.
Virology, 2018, 528:118-136. Chlorpromazine HCl purchased from Selleck.
Effects of inhibitors on GCRV infection. a Virus yield in CIK cells pretreated with vehicle, 10 mM NH4Cl, 20 μM CQ, 50 μM CPZ, or 100 μM of dynasore. b Western blotting analysis to monitor viral replication level. Cells were treated with various inhibitors as described above. After 12 h of incubation, cells were lysed and processed for Western blot analysis of GCRV-VP5 protein expression with polyclonal mouse serum. GAPDH was included as an internal loading control for the Western blots. NC denotes the negative control treated with vehicle. c Virus yield in CIK cells pretreated with vehicle, 5 μg/mL Filipin III, 50 μM LY294002, or 25 μg/mL nystatin. d Western blotting analysis to monitor the viral replication level. Cells were treated with inhibitors as described above. After 12 h of incubation, cells were lysed and processed for Western blot analysis of GCRV-VP5 protein expression with polyclonal mouse serum. GAPDH was included as an internal loading control for the Western blots. NC denotes the negative control treated with vehicle. Each experimental point is the sum of triplicate experiments with two titer assays. Error bars represent the standard errors of the mean. Asterisks represent a significant difference from the control (un-paired t-test)
Virol J, 2016, 13:25.. Chlorpromazine HCl purchased from Selleck.
Purity & Quality Control
Choose Selective Dopamine Receptor Inhibitors
|Description||Chlorpromazine HCl is a dopamine and potassium channel inhibitor with IC50 of 6.1 and 16 μM for inward-rectifying K+ currents and time-independent outward currents.|
Chlorpromazine affects miniature IPSCs (mIPSCs) by decreasing the binding (kon) and by increasing the unbinding (koff) rates of GABAARs.  Chlorpromazine modulates activated TRPA1 currents in a voltage-dependent way, leading to a block at positive potentials and an increased open probability at negative potentials. 
|In vivo||Chlorpromazine independently down-regulates the production of various T cell-derived lymphokines (IL-2, IFN-gamma, IL-4, TNF, and GM-CSF) and up-regulates the secretion of IL-10 in an in vivo model of acute superantigen-driven immune activation. Chlorpromazine -mediated amplification of the SEB-driven Chlorpromazine secretion is accompanied by an enhanced IL-10 mRNA accumulation.  Chlorpromazine protects mice, normal or adrenalectomized, and guinea pigs against lethality of LPS, and inhibits TNF serum levels. Chlorpromazine protects against LPS lethality when administered 30 minutes (min) before, simultaneously, or up to 10 min after LPS and is ineffective when given 30 min after LPS, paralleling the inhibitory effect on TNF production. Chlorpromazine significantly inhibits LPS lethality and hepatotoxicity in mice sensitized to LPS toxicity by actinomycin D, whereas under these conditions DEX is inactive.  Chlorpromazine protects brain tissue from hypoxia-induced irreversible loss of synaptic transmission in rats. Chlorpromazine also significantly delays the occurrence of the hypoxia-induced spreading depression (SD) in rats. |
-  Mozrzymas JW, et al. J Neurosci, 1999, 19(7), 2474-2488.
-  Hill K, et al. J Biol Chem, 2007, 282(10), 7145-7153.
-  Tarazona R, et al. J Immunol, 1995, 154(2), 861-870.
|In vitro||DMSO||71 mg/mL (199.81 mM)|
|Water||71 mg/mL (199.81 mM)|
|Ethanol||71 mg/mL (199.81 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
In vivo Formulation Calculator (Clear solution)
|Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)|
|Dosage||mg/kg||Average weight of animals||g||Dosing volume per animal||ul||Number of animals|
|Step 2: Enter the in vivo formulation ()|
|% DMSO % % Tween 80 % ddH2O|
Working concentration： mg/ml；
Method for preparing DMSO master liquid: ： mg drug pre-dissolved in μL DMSO (Master liquid concentration mg/mL，)
Method for preparing in vivo formulation：Take DMSO master liquid, next addμL PEG300， mix and clarify, next addμL Tween 80，mix and clarify, next add μL ddH2O，mix and clarify.
1.Please make sure the liquid is clear before adding the next solvent.
2.Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||interventions||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT03548714||Completed||Drug: PT150|Other: Beverage||Alcohol Dependence|Alcohol Interaction||Pop Test Oncology LLC|Pharmacotherapies for Alcohol and Substance Abuse Consortium|Congressionally Director Medical Research Programs|Michael Debakey Veterans Affairs Medical Center|Baylor College of Medicine|University of California San Diego||September 1 2018||Phase 1|
|NCT02943213||Completed||Drug: Chlorpromazine Hydrochloride||Anti-Psychotic|Management of Manifestations of Psychotic Disorders|Treatment of Schizophrenia|Control Nausea and Vomiting|Relief of Restlessness and Apprehension Before Surgery|Acute Intermittent Porphyria|Adjunct in the Treatment of Tetanus|Control Manifestations of the Manic Type of Mani-depressive Illness|Relief of Intractable Hiccups||Cycle Pharmaceuticals Ltd.|Parexel||November 2016||Phase 1|
|NCT02295462||Completed||Other: Person-centered Care|Other: Optimised Treatment||Dementia||Martin-Luther-Universität Halle-Wittenberg|University of Luebeck|University of Witten/Herdecke||December 2014||Not Applicable|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.